Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis

NCT06563765 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06563765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06563765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
April 10, 2024
Completion date
May 10, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ckd, renal fibrosis